Summary:

- The article discusses the growing hype and potential of using artificial intelligence (AI) in drug research and development. It highlights how AI is being used to accelerate the drug discovery process, which traditionally has been slow and expensive.

- AI-powered systems can analyze vast amounts of data, identify promising drug candidates, and simulate the effects of potential drugs on the human body, all at a much faster pace than traditional methods. This has led to increased investment and excitement around the use of AI in the pharmaceutical industry.

- However, the article also cautions that the hype around AI in drug research may be outpacing the actual results and that it will take time for the technology to fully realize its potential. Experts warn that AI is not a "silver bullet" and that it needs to be combined with human expertise and rigorous scientific methods to be truly effective in drug discovery.